Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)
ACHN.O on Nasdaq
7.74USD
22 May 2013
7.74USD
22 May 2013
Price Change (% chg)
$-0.01 (-0.13%)
$-0.01 (-0.13%)
Prev Close
$7.75
$7.75
Open
$7.78
$7.78
Day's High
$7.95
$7.95
Day's Low
$7.68
$7.68
Volume
937,512
937,512
Avg. Vol
1,132,340
1,132,340
52-wk High
$11.36
$11.36
52-wk Low
$5.42
$5.42
| SHAH GAUTAM | Options Exercised: 0 | ||
| Trade Date: | Thursday, 15 Mar 2012 | Price: | 1.05 |
| Title: | Officer | Shares Held: | 3,125 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 170 |
| Total Shares Held: | 99,804,883 |
| 3 Mo. Net Change: | 16,633,514 |
| # New Positions: | 28 |
| # Closed Positions: | 16 |
| # Increased Positions: | 102 |
| # Reduced Positions: | 53 |
| # Net Buyers: | 49 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2010 | Chairman of the Board |
Michael Kishbauch |
63 | 2004 | President, Chief Executive Officer, Director |
Mary Fenton |
48 | 2010 | Chief Financial Officer, Senior Vice President |
Gautam Shah |
56 | 2012 | Executive Vice President, Chief Compliance Officer |
Joseph Truitt |
48 | 2012 | Senior Vice President, Chief Commercial Officer |
Milind Deshpande |
55 | 2010 | President - Research and Development, Chief Scientific Officer |
Jason Fisherman |
54 | 2000 | Independent Director |
Gary Frashier |
74 | 2008 | Independent Director |
Kurt Graves |
44 | 2012 | Independent Director |
Dennis Liotta |
2008 | Independent Director | |
Robert Van Nostrand |
55 | 2007 | Independent Director |
Nicole Vitullo |
47 | 2010 | Independent Director |
David Wright |
63 | 2007 | Independent Director |

